Who
William R. Jellison
Director
Company insider
Files Form 4 as: Director, Avient; Director, Medtronic plc; Director, Masimo; Director, Anika Therapeutics; VP and CFO, Stryker; Sr. VP & C.F.O., Dentsply Sirona.
In numbers
- Trades disclosed
- 232
- Buys
- 5
- Sells
- 16
- Bought
- $1.1M
- Sold
- $18.1M
- Companies
- 6
- Companies where not an officer
- 4
- First trade
- 22 Nov 2005
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | AVNT AvientChemicals | SEC FORM 4 Code A | —958 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | AVNT AvientChemicals | SEC FORM 4 Code A | —1,049 at $0.00 | filing |
| 30 Jun 2026filed 2 Jul 2026 | AVNT AvientChemicals | SEC FORM 4 Code A | —1,049 at $0.00 | filing |
| 27 Apr 2026filed 29 Apr 2026 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code A | —1,444 at $0.00 | filing |
| 27 Apr 2026filed 29 Apr 2026 | MDT Medtronic plcMedical Devices | SEC FORM 4 Code A | —1,444 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | AVNT AvientChemicals | SEC FORM 4 Code A | —1,072 at $0.00 | filing |
| 31 Mar 2026filed 2 Apr 2026 | AVNT AvientChemicals | SEC FORM 4 Code A | —1,072 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | AVNT AvientChemicals | SEC FORM 4 Code A | —1,239 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | AVNT AvientChemicals | SEC FORM 4 Code A | —1,239 at $0.00 | filing |
| 30 Sep 2025filed 2 Oct 2025 | AVNT AvientChemicals | SEC FORM 4 Code A | —1,192 at $0.00 | filing |
| 25 Aug 2025filed 25 Aug 2025 | MDT Medtronic plcMedical Devices | SEC FORM 4 Bought | $231K2,500 at $92.37 | filing |
| 22 Aug 2025filed 25 Aug 2025 | MDT Medtronic plcMedical Devices | SEC FORM 4 Bought | $232K2,500 at $92.73 | filing |
| 11 Aug 2025filed 12 Aug 2025 | Masimo | SEC FORM 4 Bought | $438K3,000 at $145.98 | filing |
| 30 Jun 2025filed 2 Jul 2025 | AVNT AvientChemicals | SEC FORM 4 Code A | —1,187 at $0.00 | filing |
| 20 Jun 2025filed 24 Jun 2025 | ANIK Anika TherapeuticsMedical Devices | SEC FORM 4 Code A | —14,164 at $0.00 | filing |
| 29 Apr 2025filed 2 May 2025 | Masimooption or derivative | SEC FORM 4 Code M | —1,790 at $0.00 | filing |
| 29 Apr 2025filed 2 May 2025 | Masimooption or derivative | SEC FORM 4 Code A | —1,225 at $0.00 | filing |
| 29 Apr 2025filed 2 May 2025 | Masimo | SEC FORM 4 Code A | —1,790 at $0.00 | filing |
| 31 Mar 2025filed 2 Apr 2025 | AVNT AvientChemicals | SEC FORM 4 Code A | —1,055 at $0.00 | filing |
| 31 Dec 2024filed 3 Jan 2025 | AVNT AvientChemicals | SEC FORM 4 Code A | —955 at $0.00 | filing |
News
8th Circ. Panel Doubts Investors' Medtronic Insulin Pump SuitMDT · law360.com · 21 Oct 2026Dentsply Sirona to Host Third Quarter 2026 Conference Call on November 5XRAY · manilatimes.net · 20 Oct 2026Medtronic: How an Olympic Runner Found Relief From Fecal IncontinenceMDT · finanznachrichten.de · 19 Oct 2026DENTSPLY SIRONA (NASDAQ:XRAY) & Envoy Medical (NASDAQ:COCH) Financial AnalysisXRAY · tickerreport.com · 19 Oct 2026Medtronic Completes MiniMed Separation After Oversubscribed ExchangeMDT · finchannel.com · 18 Oct 2026Avient Appoints Mike Frank President And CEO - Canadian PlasticsAVNT · canplastics.com · 16 Oct 2026IceCure Medical (NASDAQ:ICCM) and DENTSPLY SIRONA (NASDAQ:XRAY) Head-To-Head ReviewXRAY · themarketsdaily.com · 15 Oct 2026Avient Stock Falls 5% After Appointing Mike Frank As CEOAVNT · finanzen.ch · 9 Oct 2026
0 headlines in the last 90 days name William R. Jellison; 9 articles from the last 14 days about the 3 companies they traded most, at most three about any one of them.